Marc Blockman
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions 8
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes 10
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 5
-
- Pharmaceutical studies and practices 7
-
- Blood Pressure and Hypertension Studies 7
- Atrial Fibrillation Management and Outcomes 6
-
- Health Systems, Economic Evaluations, Quality of Life 6
-
- HIV/AIDS drug development and treatment 5
- Co-authors
- Karen CohenB. WillemsUshma MehtaJohannes P. MoutonTamara KredoKaren I. BarnesDavid N DürrheimGary Maartens
- Journals
- British Journal of Clinical Pharmacology (4 papers)South African Medical Journal (20 papers)Drug Safety (2 papers)
- Partner nations
- South AfricaUnited KingdomUganda
In The Last Decade
Marc Blockman
64 papers receiving 744 citations
Peers
Comparison fields: 5 of 99
- Applied Microbiology and Biotechnology 110
- Toxicology 164
- Geriatrics and Gerontology 145
- Pharmacology 80
- Pediatrics, Perinatology and Child Health 178
Countries citing papers authored by Marc Blockman
This map shows the geographic impact of Marc Blockman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Blockman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Blockman more than expected).
Fields of papers citing papers by Marc Blockman
This network shows the impact of papers produced by Marc Blockman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Blockman. The network helps show where Marc Blockman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marc Blockman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 7 | |
| 9 | Safety Considerations in Cannabinoid-Based Medicine | 2020 | 4 |
| 10 | 2020 | 3 | |
| 11 | 2020 | 9 | |
| 12 | 2020 | 21 | |
| 13 | A clinical approach to drug-induced liver injury : review article | 2015 | 1 |
| 14 | Drug-induced ototoxicity : clinical pharmacology | 2009 | 1 |
| 15 | Clinical excellence and the NICEties of value-based priority setting. | 2008 | 6 |
| 16 | Possible herbal medicine-drug interactions in the perioperative period | 2008 | 1 |
| 17 | Drug interactions with the calcium-channel blockers | 2008 | 1 |
| 18 | 2007 | 104 | |
| 19 | Prescribing COMBINED ORAL CONTRACEPTIVES for women with pre-existing medical conditions | 2007 | 0 |
| 20 | Drug interactions with the calcium-channel blockers : clinical pharmacology | 2006 | 1 |
About Marc Blockman
Marc Blockman is a scholar working on Toxicology, Geriatrics and Gerontology, Family Practice, Pharmacology and Applied Microbiology and Biotechnology, having authored 75 papers that have together received 771 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmacovigilance and Adverse Drug Reactions (8 papers), Blood Pressure and Hypertension Studies (7 papers), Pharmaceutical studies and practices (7 papers), Atrial Fibrillation Management and Outcomes (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (110 citations), Toxicology (164 citations), Geriatrics and Gerontology (145 citations), Pharmacology (80 citations) and Pediatrics, Perinatology and Child Health (178 citations). Marc Blockman has collaborated with scholars based in South Africa, United Kingdom and Uganda. Frequent co-authors include Karen Cohen, B. Willems, Ushma Mehta, Johannes P. Mouton, Tamara Kredo, Karen I. Barnes, David N Dürrheim, Gary Maartens, Andy Parrish and Annemie Stewart. Their work appears in journals such as British Journal of Clinical Pharmacology, South African Medical Journal, Drug Safety, Nurse Education in Practice and AIDS Research and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.